RPC Pharma Ltd 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-20 07:30 am Purchase |
2024-05-31 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 4,507,314,800 19.200% |
1,022,356,900 (+29.34%) |
Filing |
| 2024-01-04 12:34 pm Purchase |
2024-01-01 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 3,484,957,900 26.400% |
3,484,957,900 (New Position) |
Filing |